Your browser doesn't support javascript.
loading
A case of medicine in disguise: motion sickness patches sold as medical devices containing active pharmaceutical substances.
Gaudiano, Maria Cristina; Bertocchi, Paola; De Orsi, Daniela; Manna, Livia; Antoniella, Eleonora; Rodomonte, Andrea; Sorbo, Angela; Aureli, Federica; Bartolomei, Monica.
Affiliation
  • Gaudiano MC; Centro Nazionale Controllo e Valutazione dei Farmaci, Reparto Farmaci Chimici, Istituto Superiore di Sanità, Rome, Italy.
  • Bertocchi P; Centro Nazionale Controllo e Valutazione dei Farmaci, Reparto Farmaci Chimici, Istituto Superiore di Sanità, Rome, Italy.
  • De Orsi D; Centro Nazionale Controllo e Valutazione dei Farmaci, Reparto Farmaci Chimici, Istituto Superiore di Sanità, Rome, Italy.
  • Manna L; Centro Nazionale Controllo e Valutazione dei Farmaci, Reparto Farmaci Chimici, Istituto Superiore di Sanità, Rome, Italy.
  • Antoniella E; Centro Nazionale Controllo e Valutazione dei Farmaci, Reparto Farmaci Chimici, Istituto Superiore di Sanità, Rome, Italy.
  • Rodomonte A; Centro Nazionale Controllo e Valutazione dei Farmaci, Reparto Farmaci Chimici, Istituto Superiore di Sanità, Rome, Italy.
  • Sorbo A; Dipartimento di Sicurezza Alimentare, Nutrizione e Sanità Pubblica Veterinaria, Istituto Superiore di Sanità, Rome, Italy.
  • Aureli F; Centro Nazionale Controllo e Valutazione dei Farmaci, Reparto Farmaci Chimici, Istituto Superiore di Sanità, Rome, Italy.
  • Bartolomei M; Centro Nazionale Controllo e Valutazione dei Farmaci, Reparto Farmaci Chimici, Istituto Superiore di Sanità, Rome, Italy.
Ann Ist Super Sanita ; 58(4): 254-263, 2022.
Article de En | MEDLINE | ID: mdl-36511196
ABSTRACT

INTRODUCTION:

A case study is reported on anti-motion sickness transdermal patches sold in the Internet, claiming to contain only natural ingredients but, actually, containing undeclared medicinal active substances. The visual inspection of the samples evidenced many inconsistencies in secondary and primary packaging, missing of various legal information and a non-compliant "CE" mark.

METHODS:

The qualitative analysis was performed by liquid chromatography - high resolution mass spectrometry and the quantitative by liquid chromatography with diode array detector.

RESULTS:

The analyses evidenced the presence of the antihistaminic drug Diphenhydramine and of other active substances (Capsaicin, a transdermal absorption enhancer, and Diclofenac in traces, probably a contaminant from other productions of the same plant). Moreover, the presence of several trace elements, including those potentially toxic to humans, was assessed by ICP-MS analysis.

CONCLUSIONS:

The case discussed is a new case of "medicines in disguise" never reported in literature, and shows the presence of tangible risks for public health.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Préparations pharmaceutiques Type d'étude: Qualitative_research Limites: Humans Langue: En Journal: Ann Ist Super Sanita Année: 2022 Type de document: Article Pays d'affiliation: Italie

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Préparations pharmaceutiques Type d'étude: Qualitative_research Limites: Humans Langue: En Journal: Ann Ist Super Sanita Année: 2022 Type de document: Article Pays d'affiliation: Italie